Clinical trial
Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant Epilepsy
NCT02660255 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant Epilepsy
- Lead sponsor
- University of Nebraska
- Phase
- Expanded access
- Overall status
- Approved for marketing
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.